---
layout: post
title: "iSABR Publication"
---

Individualizing dose and fractionation of radiotherapy is associated with excellent tumor control while minimizing adverse effects in treating patients' lung cancer.  

This is the conclusion of a [paper published in JAMA Oncology](https://jamanetwork.com/journals/jamaoncology/fullarticle/2809582?guestAccessKey=90b7c863-2a25-4ad8-9098-1dc9011ca890&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamaoncology&utm_content=olf&utm_term=091423&adv=null) from my time at [Stanford](https://www.stanford.edu/).  
I was able to contribute a small part to the overall endeavour.  

I contributed a very small portion 
Congratulations to [Dr. Michael Gensheimer](https://stanfordhealthcare.org/doctors/g/michael-gensheimer.html), and [Stanford Radiation Oncology](https://radonc.stanford.edu/)!  